Literature DB >> 16305926

Marsupialization of intramyocardial left anterior descending artery: a novel approach for easy access during revascularization.

Rao V Parachuri1, Binoy Chattuparambil, Praveen Kumar Hasabettu, Julius Punnen, Sanjay Dhaded, Dinesh R Sadagopan, Devi Prasad Shetty.   

Abstract

The left anterior descending (LAD) artery is the most important vessel bypassed during coronary revascularization procedures. This artery usually runs a superficial course, making it easy for localization and grafting. However, many times it takes a course deep in the myocardium or is embedded in thick epicardial fat, which results in technical challenges to the surgeon for localization and grafting. So far, many techniques are described for overcoming these problems, but all require cardiopulmonary bypass (CPB), and in fact, intramyocardial LAD is considered a relative contraindication for off-pump coronary artery bypass grafting (OPCAB). In the present era of enhanced interest in OPCAB, these techniques are not as helpful as they are for conventional CABG with CPB. Here, we describe a novel approach of marsupialization of the LAD for revascularization of intramyocardial LAD that is useful for off-pump as well as conventional revascularization procedures and makes grafting simple and reproducible.

Mesh:

Year:  2005        PMID: 16305926     DOI: 10.1016/j.athoracsur.2004.06.106

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Off-pump bilateral internal thoracic artery grafting.

Authors:  Kamales Kumar Saha
Journal:  Ann Cardiothorac Surg       Date:  2014-03

Review 2.  Off-pump coronary artery bypass grafting in India.

Authors:  Kamales Kumar Saha
Journal:  Indian Heart J       Date:  2014-03-04

Review 3.  Localizing intramyocardially embedded left anterior descending artery during coronary bypass surgery: literature review.

Authors:  Edem Ziadinov; Hilal Al-Sabti
Journal:  J Cardiothorac Surg       Date:  2013-10-30       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.